Roche Products Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
211 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 80 mg film-coated tablet blister pack.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Australian Public Assessment Report (AusPAR)Gavreto (pralsetinib) has been approved for the treatment of locally advanced or metastatic RET fusion-positive non-small cell lung cancer.